The Effect of Body Weight on Exposure, Efficacy, and Safety When Switching from Intravenous to Subcutaneous Administration of Lecanemab
Copies of this presentation obtained through the QR code are for personal use only and may not be used without permission from JSDR and the author of this poster. For permission to reprint and/or distribute, please contact Masaki Nakagawa at m5-nakagawa@hhc.eisai.co.jp
